Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

showed a trendp = 0.0741.5× alpha
Compared to the low-risk group, the incidence rate of SARS-CoV-2 pneumonia was significantly higher in the moderate-risk group (1.47-fold increase; 95% confidence intervals [CI]: 1.07–2.01, p = 0.017) and showed a trend toward being higher in the high-risk group (1.37-fold increase; 95% CI: 0.90–1.93, p = 0.074) ( Table 3 ).
showed a trendp = 0.0741.5× alpha
However, the prolonged treatment of DRG neurons in culture for 16–24 h with LTβR agonist showed a trend in sensitization of evoked APs in a subset of Nav1.8 + DRG nociceptors compared to IgG-treated neurons ( t test, t = 1.846, df = 32.53; p = 0.074; n = 15–20; Figure 2E ).
showed a trendp = 0.0741.5× alpha
As expected, we found that patients with lower baseline observed species and Chao1 indices had significantly prolonged PFS ( p = 0.0015 for observed species and p = 0.013 for Chao1, Figure 1C ), and patients with a lower Shannon index also showed a trend towards increased PFS ( p = 0.074, Figure 1C ) in those who received immunotherapy combined with chemotherapy.
showed a trendp = 0.0741.5× alpha
Patients with early improvement in lung aeration over five days showed a trend toward higher 28-day survival (75 vs 52.5%, p = 0.074), although the study was not powered to detect mortality differences, and this finding should be interpreted cautiously.
showed a trendP = 0.0741.5× alpha
In patients treated with immunotherapy ( n = 217), the high 4‐1BB group ( n = 39) showed a trend towards longer progression‐free survival (PFS) (HR = 0.70, 95%CI: 0.47‐1.04, P = 0.074; Figure 1J ) and significantly longer OS (HR = 0.55, 95%CI: 0.33‐0.89, P = 0.016; Figure 1K ) compared to the low/moderate 4‐1BB group ( n = 178) (calculated from start of immunotherapy).